Cambridge Investment Research Advisors’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.22M Sell
30,817
-51
-0.2% -$14.1K 0.02% 698
2025
Q4
$8.5M Sell
30,868
-1,206
-4% -$338K 0.02% 651
2025
Q3
$9.24M Buy
32,074
+459
+1% +$136K 0.03% 596
2025
Q2
$10.5M Buy
31,615
+3,143
+11% +$1.01M 0.03% 524
2025
Q1
$9.37M Sell
28,472
-1,391
-5% -$419K 0.03% 532
2024
Q4
$8.25M Buy
29,863
+2,277
+8% +$726K 0.03% 571
2024
Q3
$9.56M Buy
27,586
+1,513
+6% +$521K 0.03% 518
2024
Q2
$8.62M Sell
26,073
-2,064
-7% -$712K 0.03% 528
2024
Q1
$10.2M Buy
28,137
+1,265
+5% +$416K 0.04% 456
2023
Q4
$8.05M Sell
26,872
-673
-2% -$197K 0.03% 492
2023
Q3
$7.88M Sell
27,545
-283
-1% -$80.7K 0.04% 450
2023
Q2
$7.81M Sell
27,828
-541
-2% -$141K 0.04% 469
2023
Q1
$7.25M Sell
28,369
-2,299
-7% -$670K 0.04% 466
2022
Q4
$10.2M Buy
30,668
+2,797
+10% +$885K 0.05% 362
2022
Q3
$7.73M Buy
27,871
+3,100
+13% +$872K 0.04% 396
2022
Q2
$6.53M Buy
24,771
+513
+2% +$132K 0.04% 473
2022
Q1
$5.81M Sell
24,258
-4,537
-16% -$1.06M 0.03% 570
2021
Q4
$6.61M Buy
28,795
+3,701
+15% +$787K 0.03% 537
2021
Q3
$5.02M Buy
25,094
+1,159
+5% +$252K 0.02% 605
2021
Q2
$5.67M Buy
23,935
+75
+0.3% +$18.7K 0.03% 557
2021
Q1
$5.77M Sell
23,860
-473
-2% -$105K 0.03% 515
2020
Q4
$5.07M Sell
24,333
-1,356
-5% -$266K 0.03% 523
2020
Q3
$4.35M Sell
25,689
-6,886
-21% -$1.21M 0.03% 509
2020
Q2
$6.11M Buy
32,575
+10,385
+47% +$1.97M 0.05% 381
2020
Q1
$3.93M Sell
22,190
-22,937
-51% -$4.45M 0.04% 441
2019
Q4
$9.23M Buy
45,127
+3,745
+9% +$687K 0.07% 268
2019
Q3
$6.28M Buy
+41,382
New +$6.73M 0.06% 334
2019
Q2
Sell
-15,526
Closed -$2.5M 2224
2019
Q1
$2.5M Sell
15,526
-334
-2% -$61K 0.02% 630
2018
Q4
$3.01M Buy
15,860
+7,405
+88% +$1.54M 0.03% 487
2018
Q3
$1.76M Buy
8,455
+1,838
+28% +$341K 0.02% 737
2018
Q2
$1.12M Sell
6,617
-4,283
-39% -$741K 0.01% 915
2018
Q1
$1.83M Buy
10,900
+7,346
+207% +$1.43M 0.02% 658
2017
Q4
$722K Buy
3,554
+6
+0.2% +$1.19K 0.01% 1087
2017
Q3
$663K Sell
3,548
-81
-2% -$14.4K 0.01% 1059
2017
Q2
$607K Buy
3,629
+265
+8% +$42.6K 0.01% 1073
2017
Q1
$493K Buy
3,364
+106
+3% +$15.6K 0.01% 1083
2016
Q4
$435K Buy
3,258
+142
+5% +$18.6K 0.01% 1079
2016
Q3
$406K Sell
3,116
-195
-6% -$25.5K 0.01% 1147
2016
Q2
$424K Buy
3,311
+611
+23% +$80.7K 0.01% 1008
2016
Q1
$371K Sell
2,700
-90
-3% -$12.4K 0.01% 1057
2015
Q4
$408K Sell
2,790
-342
-11% -$47K 0.01% 954
2015
Q3
$423K Sell
3,132
-119
-4% -$17.3K 0.01% 844
2015
Q2
$527K Sell
3,251
-315
-9% -$43.5K 0.01% 788
2015
Q1
$462K Buy
3,566
+421
+13% +$48.9K 0.01% 836
2014
Q4
$324K Buy
3,145
+489
+18% +$48.2K 0.01% 982
2014
Q3
$241K Buy
+2,656
New +$248K 0.01% 1206

Other funds holding CI

Cambridge Investment Research Advisors's CI Position: Q1 2026 in Review

Cambridge Investment Research Advisors reduced its Cigna (CI) stake by 0.17% in Q1 2026, selling an estimated $14.1K and leaving 30,817 shares worth $8.22M. The position accounts for 0.02% of the portfolio, ranked #698.

Cambridge Investment Research Advisors first reported a position in CI in Q3 2014 and has held it in 46 quarters since. The position peaked at $10.5M in Q2 2025. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • Cambridge Investment Research Advisors held 30,817 shares of Cigna worth $8.22M as of Q1 2026.
  • Cambridge Investment Research Advisors sold 51 Cigna shares in Q1 2026, an estimated $14.1K.
  • Cigna made up 0.02% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #698 holding.
  • Cambridge Investment Research Advisors first reported a position in Cigna in Q3 2014 and has held it in 46 quarters since.
  • Cambridge Investment Research Advisors's Cigna position peaked at $10.5M in Q2 2025.
  • 1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.